MLAB — Mesa Laboratories Income Statement
0.000.00%
Last trade - 00:00- $529.72m
- $680.35m
- $240.98m
- 71
- 44
- 37
- 49
Annual income statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 134 | 184 | 219 | 216 | 241 |
| Cost of Revenue | |||||
| Gross Profit | 87 | 109 | 134 | 133 | 151 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 122 | 180 | 216 | 488 | 222 |
| Operating Profit | 12.4 | 4.7 | 3.32 | -272 | 19.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.3 | 3.57 | -0.389 | -276 | 5.96 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.27 | 1.87 | 0.93 | -254 | -1.97 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.27 | 1.87 | 0.93 | -254 | -1.97 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.27 | 1.87 | 0.93 | -254 | -1.97 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.65 | 0.351 | 0.173 | -13.9 | -0.563 |
| Dividends per Share |